Meeder Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,017
| Closed | -$62.8K | – | 985 |
|
|
2024
Q3 | $62.8K | Sell |
4,017
-704
| -15% | -$11K | ﹤0.01% | 333 |
|
|
2024
Q2 | $80.9K | Buy |
+4,721
| New | +$80.9K | 0.01% | 283 |
|
|
2021
Q4 | – | Sell |
-2
| Closed | – | – | 1953 |
|
|
2021
Q3 | $0 | Sell |
2
-1,655
| -100% | – | ﹤0.01% | 2592 |
|
|
2021
Q2 | $368K | Buy |
1,657
+382
| +30% | +$84.8K | 0.02% | 588 |
|
|
2021
Q1 | $168K | Buy |
1,275
+1,274
| +127,400% | +$168K | 0.01% | 775 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2119 |
|
|
2020
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2318 |
|
|
2020
Q2 | – | Sell |
-320
| Closed | -$22K | – | 2316 |
|
|
2020
Q1 | $22K | Sell |
320
-1,126
| -78% | -$77.4K | ﹤0.01% | 1207 |
|
|
2019
Q4 | $122K | Buy |
1,446
+807
| +126% | +$68.1K | 0.01% | 737 |
|
|
2019
Q3 | $48K | Buy |
+639
| New | +$48K | ﹤0.01% | 1031 |
|
|
2018
Q1 | – | Sell |
-3
| Closed | – | – | 1688 |
|
|
2017
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1754 |
|
|
2017
Q2 | – | Sell |
-382
| Closed | -$3K | – | 1807 |
|
|
2017
Q1 | $3K | Hold |
382
| – | – | ﹤0.01% | 1269 |
|
|
2016
Q4 | $3K | Buy |
+382
| New | +$3K | ﹤0.01% | 904 |
|